- American City Business Journals•9 days ago
Wilmington-based Charles River Laboratories, one of the state’s largest life science companies, has agreed to pay $1.8 million to settle allegations by U.S. prosecutors that it billed the National Institutes of Health for work on contracts that it didn't perform. The U.S. Department of Justice said late Monday that Charles River (CRL) had settled the allegations under the False Claims Act, which bars contractors from defrauding federal programs. The company hold contracts under which it provides the NIH with mice and other animals for use in lab tests, and maintains colonies of animals.
- Associated Press•10 days ago
BOSTON (AP) — The U.S. Department of Justice says a Massachusetts company has agreed to pay $1.8 million to settle claims it overbilled the federal government.
- Business Wire•10 days ago
Charles River Laboratories and Chiesi Farmaceutici SpA Announce Extension of Integrated Respiratory Drug Discovery Program
Charles River Laboratories International, Inc. , a leading early-stage contract research organization , today announced that it has extended its longstanding, strategic, integrated drug discovery partnership with Chiesi Farmaceutici SpA in the field of respiratory disease.
CRL : Summary for Charles River Laboratories Inte - Yahoo Finance
Charles River Laboratories International, Inc. (CRL)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Day's Range||88.10 - 88.81|
|52 Week Range||67.20 - 91.57|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||27.39|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|